1. PENETRATION ENHANCER FOR TDDS
Presented by-
Shubham N. Gharat
M.pharm
Department of Pharmaceutics
Guided by-
Prof. A. D. Savkare
Department of Pharmaceutics
M.V.P’s College of Pharmacy Nashik-2
1
2. Introduction:
• Most drug don’t have ability to penetrate stratum corneum so skin penetration
enhancer used.
• The success of penetration enhancer depends upon on the ability of the drug to
penetrate through skin in sufficient quantities to achieve the desire therapeutic
effect.
• These are the chemical which interact with skin constituents and promote the drug
flux.
2
3. Skin
• The outermost layer of skin is
SC which act as a barrier.
• Bilayer lipids and surrounding
corneocytes produce Brick and
Mortar model.
Layers:
• Stratum Corneum
• Epidermis
• Dermis
• Subcutaneous tissue
3
4. Penetration Enhancer:
• Penetration enhancer is a substance which used to promote the drug
transport across the skin barrier.
• It temporarily diminishing the barrier of the skin.
• It also known as accelerants and sorption promoters can enhance drug
flux.
4
5. Routes of penetration enhancer:
5
1. through the sweat ducts 2. directly across the stratum corneum 3. via the hair follicles
6. Factor Affecting Skin Penetration:
• pH
• Temperature
• Molecular Weight
• Partition Coefficient
• Age
• Gender
• Body site
• Skin Exposure
• Blood flow
• Skin Condition
6
7. Ideal Characteristics:
• It should reduce the barrier resistance of the stratum corneum without damaging
the cells.
• It should be non-toxic , non-irritating and non-allergic.
• It should work rapidly , the activity and duration of effect should be both
predictable and reproducible.
• It should cosmetically acceptable with an appropriate skin feel.
• The penetration enhancer should work unidirectionally.
• When penetration enhancer remove from skin , barrier properties should return
both rapidly and fully to normal.
• The substance should be an excellent solvent for drugs.
7
8. Types Of Penetration Enhancer:
Drug Vehicle Based:
• Drug Selection
• Vesicles and Particles
• Prodrug and ion pairs
• Chemical potential of Drug
• Eutectic System
• Complexes
8
14. Chemical penetration enhancer: Solvents
Alcohol :
Ethanol and Methanol
Mode of Action:
• Removal of lipids from stratum corneum results in loss of partitioning
influence on permeability.
• And large increase in the permeation rate of both polar and nonpolar
permeates.
Ex. Estradiol and Nitroglycerine
14
15. Water
Hydration of the stratum corneum will decrease in barrier function.
Hydration increase transdermal delivery of both hydrophilic and hydrophobic drug.
Mode of action:
• Water act as solvent and alter solubility of permeants and so its partitioning.
• Also on hydration corneocytes may swell and open the structure of the stratum
corneum leading to increase in permeation.
15
16. Sulfoxide
Dimethyl sulfoxide, Dimethyl acetamide, Dimethyl formamide
Mode of action :
• Extraction of stratum corneum lipids and lipoproteins.
• Interaction with the head group of bilayer lipids to distort the packing geometry.
• Delamination of horny layer(SC)
Ex. Griseofulvin, lidocaine
16
17. Pyrrolidones
Sodium pyrrolidone carboxylate, 2-pyrrolidone and N-methyl-2-pyrrolidone
Mode of action :
• Act by altering solvent nature of membrane and Pyrrolidones used to generate
reservoirs with in skin membrane.
• Such reservoir effect offers potential for sustain release of permeant.
Ex. Captopril , Caffeine , Ibuprofen
17
18. Amide
Azone
• Effective enhancer for both hydrophilic and hydrophobic drug.
• Increase in effectiveness by adding cosolvent ex. PG
Mode of action:
• Mechanisms yet unresolved
• But alterations in SC detected by DSC and FTIR.
• Azone probably act by disrupting horney layer lipid structure
Ex. Antibiotic: Clindamycin, erythromycin , Steroids: amcinonide, Indomethacin
and Naloxone.
18
19. Surfactants
Anionic surfactants:
It can penetrate and destroy the integrity of SC within hours.
Ex. Sodium Lauryl Sulphate
MOA:
• It induced swelling of SC and viable epidermis.
• The hydrophobic interaction of the alkyl chains with the substrate leaves the negative
end group of the surfactant exposed, creating additional anionic sites in the
membrane.
• This results in development of repulsive forces which separate the protein matrix,
uncoil the filaments and expose more water-binding sites.
Ex. Naproxen, Chloramphenicol
19
20. Cationic surfactant:
Alkyl amines
MOA:
• At the outer skin surface the amine has the capacity to form an ion pair with the
drug.
• The ion pair have high solubility in skin than parent anion which diffuses through
own concentration gradient to the inner sc .
• Then amine deprotonates and liberate the anion after that the amine free to travel
back to the skin surface.
• Only small amount of amine required for this carrier mechanism.
Ex. Na and K ion, Naloxone
20
21. Non-ionic surfactants:
Span 80, Tween 80
MOA:
• Increase fluidity in lipid phase of stratum corneum region which reduces
diffusional resistance.
Ex. Hydrocortisone, Lidocaine
Fatty Acid and Alcohols
MOA:
• Act as solvent and alter solubility properties of tissue leads to improve
partitioning.
• Evaporation of solvent increase drug concentration.
Ex. Acyclovir, Mannitol
21
22. Miscellaneous Chemicals:
Urea
MOA:
• It increase the hydration of SC and it also have keratolytic effects .
Ex. Hydrocortisone
N, N-Dimethyl-m-Toluamide
MOA:
• In this MOA is needs more study and usefulness on human skin is sparse.
Ex. Mosquito repellent
22
23. Calcium Thioglycolate
MOA:
• It probably involve the reduction of cystine links leading to disruption of a keratin
matrix.
Ex. Theophylline
Anticholinergic Agents
MOA:
• These agent have antisecretory effect but insufficient to cause systemic effect.
• Because API hindered by outflow of perspiration and formation of aqueous layer
on skin.
23
24. Conclusion:
• Chemical penetration enhancer are not only specific toward stratum corneum ,
they also penetrate into deeper layers of the skin to viable epidermal cells and
induce skin irritation responses.
• Penetration enhancer increase the permeation of drug but also the other
formulation excipients.
• This may lead to serious toxicological effect i.e irritation.
• Irritation produced by occlusive nature leading to accumulation of sweat and
increase in subpatch microbial growth.
• Enhancer should evaluate for irritancy under condition of long term occlusion.
24
25. References:
• Pathan IB, Setty CM. Chemical Penetration Enhancers for Transdermal Drug
Delivery. Trop J Res 2009;8(2):173-8.
• Singla V, Saini S, Sing G, Rana AC, Joshi B. Penetration Enhancers: A Novel
Strategy for Enhancing Transdermal Drug Delivery. IRJP 2011;2(12):32-6.
• Walters KA. Penetration Enhancer and Their Use in Transdermal Therapeutic
Systems. In: Hadgraft J, Guy RH, editor. Transdermal Drug Delivery
Development Issues and Research Initiatives, Vol-35, 1st ed. New York: Marcel
Dekker, Inc: p. 197-232.
• Mathur, V., Satrawala, Y. and Rajput, M.S., 2014. Physical and chemical
penetration enhancers in transdermal drug delivery system. Asian Journal of
Pharmaceutics (AJP): Free full text articles from Asian J Pharm, 4(3).
25